Acessibilidade
A+
A-
Institucional
EN
PT
2030 Commitments
Material Topics
GRI
SASB
TCFD
Ratings
MSCI
Policies
SASB
Home
>
SASB
>
Medicine supply chain integrity
Data pertaining to 2024
Overview
Retail energy management
Controlled substances management
Medicine supply chain integrity
Activity metrics
Patient health outcomes
Data security and privacy
Medicine supply chain integrity
Choose a disclosure
HC-DR-250a.1
HC-DR-250a.2
HC-DR-250a.1
Description of efforts to reduce the occurrence of compromised drugs within the supply chain
HC-DR-250a.2
Number of drug recalls issued, Total units recalled, Percentage for private-label products
© 2025 RaiaDrogasil – Todos os direitos reservados.
Produzido por
Plank
